advertisement
11.4 Prostaglandins (21)
Showing records 1 to 21
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins21104 Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears
Kahook MY; Noecker RJ
Cornea 2008; 27: 339-343
21320 A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides
Albert DM; Gangnon RE; Grossniklaus HE; Green WR; Darjatmoko S; Kulkarni AD
Archives of Ophthalmology 2008; 126: 626-631
21114 Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%
Frenkel RE; Noecker RJ; Craven ER
Current Medical Research and Opinion 2008; 24: 919-923
20982 Discrepancy of the intraocular pressure response between fellow eyes in one-eye trials versus bilateral treatment: Verification with normal subjects
Takahashi M; Higashide T; Sakurai M; Sugiyama K
Journal of Glaucoma 2008; 17: 169-174
21155 Effects of switching from topical β-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma
Ikeda Y; Mori K; Ishibashi T; Naruse S; Nakajima N; Kinoshita S
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 230-234
21418 Predicting intraocular pressure change before initiating therapy: Timolol versus latanoprost
van der Valk R; Webers CAB; Hendrikse F; de Vogel SC; Prins MH; Schouten JSAG
Acta Ophthalmologica 2008; 86: 415-418
21030 Induction by latanoprost of collagen gel contraction mediated by human tenon fibroblasts: Role of intracellular signaling molecules
Liu Y; Ko JA; Yanai R; Kimura K; Chikama T; Sagara T; Nishida T
Investigative Ophthalmology and Visual Science 2008; 49: 1429-1436
21395 Comparison of ocular surface side effects of topical travoprost and bimatoprost
Alagöz G; Bayer A; Boran C; Serin D; Kükner A; Elçioğlu M
Ophthalmologica 2008; 22: 161-167
20949 Orbital fat atrophy in glaucoma patients treated with topical bimatoprost - can bimatoprost cause enophthalmos?
Tappeiner C; Perren B; Iliev ME; Frueh BE; Goldblum D
Klinische Monatsblätter für Augenheilkunde 2008; 225: 443-445
20988 Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study
Lim KS; Nau CB; O'Byrne MM; Hodge DO; Toris CB; McLaren JW; Johnson DH
Ophthalmology 2008; 115: 790-795
21140 Effects of unoprostone on phosphorylated extracellular signal-regulated kinase expression in endothelin-1-induced retinal and optic nerve damage
Munemasa Y; Kitaoka Y; Hayashi Y; Takeda H; Fujino H; Ohtani-Kaneko R; Hirata K; Ueno S
Visual Neuroscience 2008; 25: 197-208
21156 Latanoprost-induced stabilization of central visual function in patients with primary open-angle glaucoma
Evans DW; Bartlett JD; Houde B; Than TP; Shaikh A
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 224-229
20974 Duration of IOP reduction with travoprost BAK-free solution
Gross RL; Peace JH; Smith SE; Walters TR; Dubiner HB; Weiss MJ; Ochsner KI
Journal of Glaucoma 2008; 17: 217-222
20933 The one-eye trial and fellow eye response to prostaglandin analogues
Dayanir V; Cakmak H; Berkit I
Clinical and Experimental Ophthalmology 2008; 36: 136-141
20971 Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost
Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
Journal of Glaucoma 2008; 17: 233-237
20901 A 5-year, randomized, open-label safety study of latanoprost and usual care in patients with open-angle glaucoma or ocular hypertension
Goldberg I; Li XY; Selaru P; Paggiarino D
European Journal of Ophthalmology 2008; 18: 408-416
20892 Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments
Hernández M; Urcola JH; Vecino E
Experimental Eye Research 2008; 86: 798-806
21419 Success rates for switching to dorzolamide/timolol fixed combination in timolol responders who are insufficiently controlled by latanoprost monotherapy
Sonty S; Henry JC; Sharpe ED; Weiss MJ; Stewart JA; Nelson LA; Stewart WC
Acta Ophthalmologica 2008; 86: 419-423
21154 Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension
Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
Annals of Pharmacotherapy 2008; 42: 498-504
21037 Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost
Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C
Current Eye Research 2008; 33: 477-482
20879 In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line
Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
Current Eye Research 2008; 33: 303-312
